Northern Trust’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,118,652
Closed -$4.25M 4335
2020
Q1
$4.25M Buy
1,118,652
+14,747
+1% +$56K ﹤0.01% 2397
2019
Q4
$5.62M Sell
1,103,905
-16,536
-1% -$84.2K ﹤0.01% 2508
2019
Q3
$5.66M Buy
1,120,441
+69,184
+7% +$350K ﹤0.01% 2477
2019
Q2
$6.49M Sell
1,051,257
-25,084
-2% -$155K ﹤0.01% 2408
2019
Q1
$4.99M Buy
1,076,341
+10,295
+1% +$47.8K ﹤0.01% 2562
2018
Q4
$4.48M Sell
1,066,046
-15,057
-1% -$63.2K ﹤0.01% 2569
2018
Q3
$6.78M Buy
1,081,103
+146,283
+16% +$917K ﹤0.01% 2502
2018
Q2
$7.52M Buy
934,820
+59,558
+7% +$479K ﹤0.01% 2450
2018
Q1
$6.53M Sell
875,262
-579
-0.1% -$4.32K ﹤0.01% 2427
2017
Q4
$5.21M Sell
875,841
-10,775
-1% -$64.1K ﹤0.01% 2577
2017
Q3
$6.53M Sell
886,616
-8,842
-1% -$65.1K ﹤0.01% 2458
2017
Q2
$6.08M Buy
895,458
+33,774
+4% +$229K ﹤0.01% 2497
2017
Q1
$8.14M Buy
861,684
+38,773
+5% +$366K ﹤0.01% 2254
2016
Q4
$7.11M Buy
822,911
+23,660
+3% +$204K ﹤0.01% 2324
2016
Q3
$5.06M Sell
799,251
-9,583
-1% -$60.7K ﹤0.01% 2509
2016
Q2
$3.41M Sell
808,834
-7,865
-1% -$33.2K ﹤0.01% 2714
2016
Q1
$3.56M Buy
816,699
+28,440
+4% +$124K ﹤0.01% 2637
2015
Q4
$4.83M Buy
788,259
+11,492
+1% +$70.4K ﹤0.01% 2482
2015
Q3
$4.44M Buy
776,767
+48,987
+7% +$280K ﹤0.01% 2505
2015
Q2
$5.43M Sell
727,780
-3,950
-0.5% -$29.5K ﹤0.01% 2464
2015
Q1
$4.38M Buy
731,730
+13,325
+2% +$79.7K ﹤0.01% 2585
2014
Q4
$5.43M Sell
718,405
-25,224
-3% -$191K ﹤0.01% 2455
2014
Q3
$3.86M Sell
743,629
-25,671
-3% -$133K ﹤0.01% 2684
2014
Q2
$3.32M Sell
769,300
-19,555
-2% -$84.3K ﹤0.01% 2792
2014
Q1
$3.23M Sell
788,855
-67,634
-8% -$277K ﹤0.01% 2840
2013
Q4
$4.57M Buy
856,489
+51,706
+6% +$276K ﹤0.01% 2635
2013
Q3
$4.04M Buy
804,783
+121,430
+18% +$610K ﹤0.01% 2656
2013
Q2
$3.05M Buy
+683,353
New +$3.05M ﹤0.01% 2721